Last reviewed · How we verify
NCT04806984
Improving Gap Closure Rates Using a Predictive Model
trial testing Participant outreach in Communication in 34,896 participants. Completed in 27 February 2022.
27 February 2022
Quick facts
| Lead sponsor | NYU Langone Health |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 34,896 |
| Start date | 9 February 2021 |
| Primary completion | 27 February 2022 |
| Estimated completion | 27 February 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Participant outreach
Conditions studied
- Communication — all drugs for Communication →
- Appointments and Schedules — all drugs for Appointments and Schedules →
Sponsor
NYU Langone Health — full company profile →
Who can join
3 and older, any sex, with Communication or Appointments and Schedules. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
NYU Langone Health outreaches to patients to remind them to schedule their appointments by phone or MyChart message.The proposed study will test different outreach methods using a predictive risk model. The goal is to increase gap closure rate by the end of the year.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04806984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Communication
Currently open trials in the same condition.
- NCT07303517 — AI-Driven Consent Simplification Study · recruiting
- NCT07215507 — Timing of Physician Rounds for Antepartum Patients · NA · recruiting
- NCT06993688 — Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit · NA · recruiting
- NCT06913010 — DV 100 as a Framework for the Hospital Incident Command System · recruiting
- NCT07137377 — Assessing the Impact of Therapeutic Communication on Patients' Anxiety During Elective Cesarean Sections · NA · recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
- NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
- NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
- NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
- NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
- NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04806984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
- Last refreshed: 28 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04806984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing